Dermatofibrosarcoma protuberans of the breast: A case study

Dimas,Dionysios; Boutas,Ioannis; Potiris,Anastasios; Koufopoulos,Nektarios; Balalis,Dimitrios; Sitara,Kyparissia; Danglis,Fotios; Misitzis,Ioannis

doi:10.3892/mco.2021.2212

Dermatofibrosarcoma protuberans of the breast: A case study

Authors:
- Dionysios Dimas
- Ioannis Boutas
- Anastasios Potiris
- Nektarios Koufopoulos
- Dimitrios Balalis
- Kyparissia Sitara
- Fotios Danglis
- Ioannis Misitzis
View Affiliations

Affiliations: Breast Unit, Athens Medical Center, Psychiko Clinic, Athens 11525, Greece, Third Department of Obstetrics and Gynecology, Attikon University Hospital, National and Kapodistrian University of Athens, Athens 12462, Greece, Second Department of Pathology, Attikon University Hospital, National and Kapodistrian University of Athens, Athens 12462, Greece, Department of Surgery, Saint Savvas Anti‑Cancer Hospital, Athens 11521, Greece, Surgical Pathology Department, National and Kapodistrian University of Athens, Athens 15125, Greece
Published online on: January 20, 2021 https://doi.org/10.3892/mco.2021.2212
Article Number: 50

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Dermatofibrosarcoma protuberans (DFSP) is a superficial mesenchymal neoplasm that originates from the dermal fibroblasts and tends to be locally aggressive. Although infrequent, it is one of the most common cutaneous sarcomas. It mainly affects young and middle‑aged patients 20 to 50 years old. Any area of skin may be involved, but the most common sites of presentation are the trunk and extremities. DFSP of the breast is extremely rare. It classically presents as a nodular, exophytic, cutaneous mass, though initially it can manifest as a flat plague and can show persistent but slow growth for many years. Due to increased risk of local recurrence, the standard of care for localized disease is surgical excision with adequate margins. Wide local excision is the most common technique used, but as an alternative Mohs micrographic surgery has emerged as a procedure that offers lower local recurrence rates. Metastases are rare but have been previously reported. In such patients, treatment with imatinib or radiotherapy can be considered. The current case presents a 52‑year‑old lady with DFSP of the breast that was successfully managed by the Breast Unit of Athens Medical Center‑Psychiko Clinic.

View Figures

View References

1	Cottier O, Fiche M, Meuwly JY and Delaloye JF: Dermatofibrosarcoma presenting as a nodule in the breast of a 75-year-old woman: A case report. J Med Case Rep. 5(503)2011.PubMed/NCBI View Article : Google Scholar
2	Bowne WB, Antonescu CR, Leung DH, Katz SC, Hawkins WG, Woodruff JM, Brennan MF and Lewis JJ: Dermatofibrosarcoma protuberans: A clinicopathologic analysis of patients treated and followed at a single institution. Cancer. 88:2711–2720. 2000.PubMed/NCBI
3	Dragoumis DM, Katsohi LA, Amplianitis IK and Tsiftsoglou AP: Late local recurrence of dermatofibrosarcoma protuberans in the skin of female breast. World J Surg Oncol. 8(48)2010.PubMed/NCBI View Article : Google Scholar
4	Woo KJ, Bang SI, Mun GH, Oh KS, Pyon JK and Lim SY: Long-term outcomes of surgical treatment for dermatofibrosarcoma protuberans according to width of gross resection margin. J Plast Reconstr Aesthet Surg. 69:395–401. 2016.PubMed/NCBI View Article : Google Scholar
5	Loghdey MS, Varma S, Rajpara SM, Al-Rawi H, Perks G and Perkins W: Mohs micrographic surgery for dermatofibrosarcoma protuberans (DFSP): A single-centre series of 76 patients treated by frozen-section Mohs micrographic surgery with a review of the literature. J Plast Reconstr Aesthet Surg. 67:1315–1321. 2014.PubMed/NCBI View Article : Google Scholar
6	Lee SJ, Mahoney MC and Shaughnessy E: Dermatofibrosarcoma protuberans of the breast: Imaging features and review of the literature. AJR Am J Roentgenol. 193:W64–W69. 2009.PubMed/NCBI View Article : Google Scholar
7	Saiag P, Grob JJ, Lebbe C, Malvehy J, del Marmol V, Pehamberger H, Peris K, Stratigos A, Middelton M, Basholt L, et al: Diagnosis and treatment of dermatofibrosarcoma protuberans. European consensus-based interdisciplinary guideline. Eur J Cancer. 51:2604–2608. 2015.PubMed/NCBI View Article : Google Scholar
8	Taylor HB and Helwig EB: Dermatofibrosarcoma protuberans. A study of 115 cases. Cancer. 15:717–725. 1962.PubMed/NCBI View Article : Google Scholar
9	Bague S and Folpe AL: Dermatofibrosarcoma protuberans presenting as a subcutaneous mass: A clinicopathological study of 15 cases with exclusive or near-exclusive subcutaneous involvement. Am J Dermatopathol. 30:327–232. 2008.PubMed/NCBI View Article : Google Scholar
10	Ugurel S, Kortmann RD, Mohr P, Mentzel T, Garbe C and Breuninger H: Short German guidelines: Dermatofibrosarcoma protuberans. J Dtsch Dermatol Ges. 6 (Suppl 1):S17–S18. 2008.PubMed/NCBI View Article : Google Scholar : (In English, German).
11	Stamatakos M, Fyllos A, Siafogianni A, Ntzeros K, Tasiopoulou G, Rozis M and Kontzoglou K: Dermatofibrosarcoma protuberans: A rare entity and review of the literature. J Buon. 19:34–41. 2014.PubMed/NCBI
12	Nakanishi G, Lin SN, Asagoe K, Suzuki N, Matsuo A, Tanaka R, Makino E, Fujimoto W and Iwatsuki K: A novel fusion gene of collagen type I alpha 1 (exon 31) and platelet-derived growth factor B-chain (exon 2) in dermatofibrosarcoma protuberans. Eur J Dermatol. 17:217–219. 2007.PubMed/NCBI View Article : Google Scholar
13	Sadullahoglu C, Dere Y, Atasever TR, Oztop MT and Karaaslan O: The Role of CD34 and D2-40 in the differentiation of dermatofibroma and dermatofibrosarcoma protuberans. Turk Patoloji Derg. 1:223–227. 2017.PubMed/NCBI View Article : Google Scholar
14	Snow SN, Gordon EM, Larson PO, Bagheri MM, Bentz ML and Sable DB: Dermatofibrosarcoma protuberans: A report on 29 patients treated by Mohs micrographic surgery with long-term follow-up and review of the literature. Cancer. 101:28–38. 2004.PubMed/NCBI View Article : Google Scholar
15	Malan M, Xuejingzi W and Quan SJ: The efficacy of Mohs micrographic surgery over the traditional wide local excision surgery in the cure of dermatofibrosarcoma protuberans. Pan Afr Med J. 33(297)2019.PubMed/NCBI View Article : Google Scholar
16	Meguerditchian AN, Wang J, Lema B, Kraybill WG, Zeitouni NC and Kane JM III: Wide excision or Mohs micrographic surgery for the treatment of primary dermatofibrosarcoma protuberans. Am J Clin Oncol. 33:300–303. 2010.PubMed/NCBI View Article : Google Scholar
17	Maji S, Paul MJ and Sen S: Dermatofibrosarcoma protuberans of the breast-a rare entity. Indian J Surg Oncol. 9:351–354. 2018.PubMed/NCBI View Article : Google Scholar
18	Llombart B, Serra-Guillen C, Monteagudo C, Lopez Guerrero JA and Sanmartin O: Dermatofibrosarcoma protuberans: A comprehensive review and update on diagnosis and management. Semin Diagn Pathol. 30:13–28. 2013.PubMed/NCBI View Article : Google Scholar
19	Popov P, Bohling T, Asko-Seljavaara S and Tukiainen E: Microscopic margins and results of surgery for dermatofibrosarcoma protuberans. Plast Reconstr Surg. 119:1779–1784. 2007.PubMed/NCBI View Article : Google Scholar
20	Pohlodek K, Meciarova I, Grossmann P and Kinkor Z: Dermatofibrosarcoma protuberans of the breast: A case report. Oncol Lett. 14:993–998. 2017.PubMed/NCBI View Article : Google Scholar
21	Rutgers EJ, Kroon BB, Albus-Lutter CE and Gortzak E: Dermatofibrosarcoma protuberans: Treatment and prognosis. Eur J Surg Oncol. 18:241–248. 1992.PubMed/NCBI